Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1764-1774
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Table 3 Sensitivity and specificity of variables at week 14 as predictors of long-term mucosal healing
| Variable | Sensitivity | Specificity |
| CDEIS < 3 | 69 | 67 |
| CDEIS < 4 | 62 | 78 |
| 80% reduction of CDEIS (baseline to week 14) | 59 | 91 |
| Endoscopic response at week 14 | 85 | 66 |
| Endoscopic remission at week 14 | 59 | 85 |
- Citation: Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1764